By: Susan Van Meter, Executive Director, AdvaMedDx A Response to 2017 JAMA Oncology Study: Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing Recently, researchers at Brigham and Women’s Hospital published an article in JAMA Oncology that sought to compare the performance of FDA-approved companion diagnostics…

By Patrick Daly, President and CEO, Cohera Medical, and Chairman, AdvaMed Accel Most people are familiar with the saying, “Big things come in small packages.” What most may not realize is that some of the biggest innovations in medical technology come from small companies. …

Diagnostic Tests Can Help Prevent Antibiotic Resistance and Save Lives — If We Just Use Them By Andrew Fish, Executive Director of AdvaMedDx As any parent has experienced when their child is sick, it may seem like the right course of action to visit the pediatrician and request an antibiotic for what ails them. …

By Josh Levine, Chair, AdvaMed Radiation Therapy Sector, President and CEO, Accuray This year alone, more than 12 million people around the world will be diagnosed with cancer, and 8 million people will die from the disease. While cancer continues to be a major worldwide health concern, and as World…

By Scott Whitaker, President and CEO, AdvaMed Enactment of the 21st Century Cures Act represents the culmination of more than two years of bipartisan work by members of the House and Senate — led by House Energy and Commerce Committee Chairman Fred Upton (R-MI) and Committee Member Diana DeGette (D-CO)…

By Kenneth Morton, U.S. Navy veteran and product support specialist, Elekta I am proud to have served our country as a sailor in the United States Navy for twenty years. Today, I am proud to serve people in need as a product support specialist in the medical technology industry. The…

By Scott Whitaker, President and CEO, AdvaMed In recognition of October as National Breast Cancer Awareness Month, it’s important to remember that advancements in medical technology in recent decades have helped save the lives of millions of cancer patients, perhaps even some who are close to you. …

By Scott Whitaker, President and CEO, AdvaMed This past January, the Centers for Medicare and Medicaid Services began an aggressive timeline to phase in $4.4 …

Time To Fully Repeal The Medical Device Tax By Scott Whitaker, President and CEO, AdvaMed America’s medical device and diagnostics industry helps deliver life-changing medical advancements to patients in need. …